J&J warns doctors of Doxil cancer-drug shortage (Reuters)
Reuters – Johnson & Johnson has cautioned doctors not to begin treatment with its Doxil cancer drug because of shortages of the medicine made by an outside manufacturer.
Good Health is Your Greatest Wealth……Virgil
Reuters – Johnson & Johnson has cautioned doctors not to begin treatment with its Doxil cancer drug because of shortages of the medicine made by an outside manufacturer.